Work

Impact of Plasmodium falciparum exposure on SARS-CoV-2 antibody responses, infection and outcomes: a cross-sectional study in Manhiça, Mozambique

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background SARS-CoV-2 and Plasmodium falciparum coexist in Africa, raising questions about potential immunological interactions between both pathogens, which could have impacted the COVID-19 pandemic in the continent. However, few studies have assessed the relationship between malaria exposure and SARS-CoV-2 infection, symptomatology, and potential antibody cross-reactivity. Methods We conducted a sero-epidemiological study using plasma samples collected in Mozambique and Spain between 2001 and 2022. IgG, IgM, and IgA responses to spike (S) and nucleocapsid (N) SARS-CoV-2 and blood stage P. falciparum antigens were measured using a multiplex assay to evaluate potential cross-reactivity between antibodies. COVID-19 pre-pandemic samples from Mozambique ( n = 175) and Spain ( n = 35) were used to assess baseline IgG cross-reactivity. Post-pandemic samples from 2,576 individuals in Manhiça, Mozambique (2021–2022), were analyzed to examine associations between malaria exposure, quantified by a composite malaria IgG score, and SARS-CoV-2 infection, seropositivity and COVID-19 symptomatology. Statistical tests included t-tests, Spearman correlations, and unadjusted logistic regressions. Results The quantitative suspension array antibody assay to assess SARS-CoV-2 seropositivity achieved high sensitivity (IgG: 85%; IgA: 75%) and specificity (> 93%), with best performance for S and receptor-binding domain (RBD) antigens. Pre-pandemic African samples showed significantly higher anti-SARS-CoV-2 IgG reactivity than the European ones ( p < 0.0001). In pre-pandemic samples, moderate correlations were observed between anti– P. falciparum and anti–SARS-CoV-2 IgG (e.g., RBD vs. EBA-175, r = 0.41, p < 0.001). In post-pandemic samples, correlations weakened with rising SARS-CoV-2 seroprevalence. Prior exposure to malaria was not associated with SARS-CoV-2 infection, SARS-CoV-2 seropositivity or COVID-19 symptomatology. Conclusions Our findings demonstrate evidence of serological cross-reactivity between antibodies against P. falciparum and SARS-CoV-2 in pre-pandemic African samples. These results highlight the importance of sero-surveillance approaches that account for co-endemic pathogens to better inform public health strategies in these co-endemic regions. Clinical Trial Not applicable.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7229748625
FWCI:
Cites:
Cited by:
Related to: 10